Pregled bibliografske jedinice broj: 1135435
Associated risk factors for hepatitis E seroprevalence among liver transplant recipients
Associated risk factors for hepatitis E seroprevalence among liver transplant recipients // Abstract Book. U: Journal of hepatology, 70(Suppl.1)
Beč, Austrija, 2019. str. e719-e720 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1135435 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Associated risk factors for hepatitis E
seroprevalence among liver transplant recipients
Autori
Dinjar Kujundžić, Petra ; Đaković Rode, Oktavija ; Vince, Adriana ; Prpić, Jelena ; Jemeršić, Lorena ; Kolarić, Branko ; Ostojić, Ana ; Mrzljak, Anna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstract Book. U: Journal of hepatology, 70(Suppl.1)
/ - , 2019, E719-e720
Skup
The International Liver Congress 2019
Mjesto i datum
Beč, Austrija, 10.04.2019. - 14.04.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Hepatitis E virus ; Croatia ; liver ; transplantation
Sažetak
Background and aims: Hepatitis E virus (HEV) is an emerging disease in Europe, especially important among solid organ transplant (SOT) recipients who are at greater risk of developing acute and chronic graft hepatitis with progression to cirrhosis. It is proposed that foodborne transmission is the main route of HEV infection in developed countries. However, risk factors for the acquisition of HEV infection among SOT recipients are incompletely understood. This study aimed to determine exposure of HEV infection and associated socio-demographic risk factors. Background and aims: In this cross-sectional study, 242 Croatian SOT recipients were screened during routine post- transplant outpatient visits. All participants completed a risk factor assessment questionnaire. Blood samples were tested for anti-HEV IgG using an enzyme immune assay (Mikrogen, Germany) and nucleic acid extracts of whole blood were tested by an in- house real-time reverse-transcriptase polymerase chain reaction assay for HEV RNA. Results: Anti-HEV IgG seroprevalence in Croatian SOT recipients was 24.38%. No SOT patients had HEV viraemia at time of testing. The median time after transplant was 5 years (range 19 years). The majority of the recipients were male (69.0%) and major indication for SOTwas alcoholic liver disease (50.4%). Older age (OR = 1.05 ; 95%CI = 1.02-1.09), female gender (OR = 2.61 ; 95%CI = 1.42-4.81), rural area of residence (AOR = 2.17 ; 95%CI = 1.10-4.27), and specific factors within a household: a farm (AOR = 2.79 ; 95% CI = 1.31- 5.92), a water-well (AOR = 3.09 ; 95%CI = 1.11- 8.57) and a sewage system connected to a septic tank (AOR = 3.38 ; 95%CI = 1.64-6.95) were detected as potential risk factors, while highest level of education (AOR = 0.05 ; 95%CI = 0.01- 0.43) and a recent travelling experience (AOR = 0.39 ; 95%CI = 0.17-0.88) as protective factors. Contrary to initial assumptions, production and/or consummation of cured meat and occupational exposure had no statistically significant strength of association with anti-HEV IgG seropositivity. Conclusion: Prevalence of anti-HEV IgG in SOT recipients in Croatia is 24.38%. Identified socio- demographic factors associated with the seropositivity set up a platform for further research directions to evaluate sources/routes of transmission and clinical impact of HEV infection after SOT.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Hrvatski veterinarski institut, Zagreb,
Veterinarski fakultet, Zagreb,
Medicinski fakultet, Rijeka,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Sveučilište u Zagrebu,
Sveučilište u Rijeci
Profili:
Branko Kolarić
(autor)
Anna Mrzljak
(autor)
Ana Ostojić
(autor)
Adriana Vince
(autor)
Jelena Prpić
(autor)
Oktavija Dakovic Rode
(autor)
Lorena Jemeršić
(autor)